CYFANTIR Trademark

Trademark Overview

On Thursday, January 30, 2014, a trademark application was filed for CYFANTIR with the United States Patent and Trademark Office. The USPTO has given the CYFANTIR trademark a serial number of 86179771. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, September 18, 2017. This trademark is owned by Vertex Pharmaceuticals Incorporated. The CYFANTIR trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of hepatitis, cystic fibrosis, influenza, cancer, viral and bacterial infections, inflammatory bowel disease, neurological disorders and autoimmune diseases
cyfantir

General Information

Serial Number86179771
Word MarkCYFANTIR
Filing DateThursday, January 30, 2014
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, September 18, 2017
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, June 17, 2014

Trademark Statements

Goods and ServicesPharmaceutical preparations for the treatment of hepatitis, cystic fibrosis, influenza, cancer, viral and bacterial infections, inflammatory bowel disease, neurological disorders and autoimmune diseases

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, February 11, 2014
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameVertex Pharmaceuticals Incorporated
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressBoston, MA 02210
Party NameVertex Pharmaceuticals Incorporated
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressBoston, MA 02210

Trademark Events

Event DateEvent Description
Monday, September 18, 2017ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, September 18, 2017ABANDONMENT - NO USE STATEMENT FILED
Wednesday, January 25, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, January 24, 2017EXTENSION 5 GRANTED
Friday, January 20, 2017EXTENSION 5 FILED
Friday, January 20, 2017TEAS EXTENSION RECEIVED
Tuesday, September 6, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Saturday, September 3, 2016EXTENSION 4 GRANTED
Friday, August 5, 2016EXTENSION 4 FILED
Friday, August 5, 2016TEAS EXTENSION RECEIVED
Thursday, March 17, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, March 16, 2016EXTENSION 3 GRANTED
Friday, February 12, 2016EXTENSION 3 FILED
Friday, February 12, 2016TEAS EXTENSION RECEIVED
Thursday, August 27, 2015NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, August 26, 2015EXTENSION 2 GRANTED
Monday, August 10, 2015EXTENSION 2 FILED
Wednesday, August 26, 2015CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, August 10, 2015TEAS EXTENSION RECEIVED
Saturday, January 24, 2015NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, January 22, 2015EXTENSION 1 GRANTED
Thursday, January 22, 2015EXTENSION 1 FILED
Thursday, January 22, 2015TEAS EXTENSION RECEIVED
Tuesday, August 12, 2014NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, June 17, 2014OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, June 17, 2014PUBLISHED FOR OPPOSITION
Wednesday, May 28, 2014NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Friday, May 9, 2014APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, May 6, 2014ASSIGNED TO EXAMINER
Tuesday, February 11, 2014NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Monday, February 3, 2014NEW APPLICATION ENTERED IN TRAM

Related Keywords

cyfantir bowel inflammatory infections disease neurological diseases autoimmune disorders bacterial viral